Lupus drug benlysta proves safe and effective in large Real-World study

NCT ID NCT03370263

First seen Feb 01, 2026 · Last updated May 06, 2026 · Updated 12 times

Summary

This study looked at how safe and effective Benlysta is for people with lupus when used in everyday medical practice. Over 1,500 patients were followed for one year after starting the drug. Researchers tracked disease activity, quality of life, and any side effects to ensure the medicine is used properly.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS ERYTHEMATOSUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • GSK Investigational Site

    Hiroshima, 730-0001, Japan

Conditions

Explore the condition pages connected to this study.